CBLL

CeriBell (CBLL)

About CeriBell (CBLL)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Details

Daily high
$20.59
Daily low
$19.57
Price at open
$19.60
52 Week High
$24.33
52 Week Low
$10.85
Market cap
735.9M
Dividend yield
0.00%
Volume
265,943
Avg. volume
258,181
P/E ratio
-13.38

CeriBell News

Details

Daily high
$20.59
Daily low
$19.57
Price at open
$19.60
52 Week High
$24.33
52 Week Low
$10.85
Market cap
735.9M
Dividend yield
0.00%
Volume
265,943
Avg. volume
258,181
P/E ratio
-13.38